(888) 552-6760 SCHEDULE AN APPOINTMENT

Krisstina Gowin,

Hematologist and Integrative Medicine

Biography photo
Location
City of Hope Orange County Lennar Foundation Cancer Center
1000 Five Point
Irvine, CA 92618
Education
Medical school:
Board Certifications
  • 2012 American Board of Internal Medicine Internal Medicine Certification
  • 2016 American Board of Internal Medicine Oncology Certification
  • 2016 Washington State Osteopathic Physician & Surgeon License
  • 2017 American Board of Internal Medicine Hematology Certification
  • 2017 Medical Board of California Physician & Surgeon A
  • 2018 Arizona Board of Osteopathic License
  • 2022 American Board of Physicians Specialties, Integrative Medicine Certification
Degrees
  • 2009, Doctor of Osteopathic Medicine, Chicago College of Osteopathic Medicine; Chicago, Illinois
  • 2005, Master of Arts, Molecular, Cellular, and Developmental Biology, University of California; Santa Barbara, California
  • 2003, Bachelor of Arts, Biological Science, University of California; Santa Barbara, California
Fellowships
  • 2015-2017, Integrative Medicine Fellowship, University of Arizona; Tucson, Arizona
  • 2012-2016, Hematology/Oncology Fellowship, Mayo Clinic; Scottsdale, Arizona
Residency
  • 2008-2012, Internal Medicine Residency, University of Southern California; Los Angeles, California
Professional Experience
  • 2024-present, Education Director, Cherng Family Center for Integrative; Oncology and Associate Clinical Professor, Medical Oncology and Therapeutics Research, City of Hope Orange County; Irvine, California
  • 2023-2024, Associate Professor of Medicine, Clinical Scholar, Division of Hematology/Oncology, University of Arizona Cancer Center; Tucson, Arizona
  • 2018-2023, Assistant Professor of Medicine, Clinical Scholar, Division of Hematology/Oncology, University of Arizona Cancer Center; Tucson, Arizona
  • 2016-2018, Staff Physician, Hematologist/Oncologist, Salish Integrative Cancer Center; Fife, Washington
Academic Appointments
  • Education Director, Cherng Family Center for Integrative Oncology
  • Associate Clinical Professor, Medical Oncology and Therapeutics Research, Department of Supportive Care Medicine
About Me

Krisstina Gowin, D.O., leads education at City of Hope’s Cherng Family Center for Integrative Oncology, one of the first cancer center-based integrative medicine programs. With over 40 percent of cancer patients currently seeking integrative care, Dr. Gowin’s expertise in integrative therapies is vital to those interested in innovative approaches to support cancer treatment and healing.

“I want patients to know they are not alone in seeking these therapies and there are evidence-based resources to help them,” she says.

A hematologist/oncologist, Dr. Gowin is also an expert in myeloproliferative neoplasms (MPN), a rare blood cancer. She has authored numerous studies and Living Well with Myeloproliferative Neoplasm, a guide addressing an integrative and wellness-based approach to patient care.

Dr. Gowin completed her Hematology Oncology fellowship at the Mayo Clinic Arizona and her Integrative fellowship at Andrew Weil Center for Integrative Medicine at the University of Arizona, where she later directed the fellowship program. She completed a residency in internal medicine at the University of Southern California and medical training at Chicago College of Osteopathic Medicine.

Recognized for her commitment to whole-person healing, she has received awards such as the Humanism in Medicine Award.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.